78 reports

EXECUTIVE SUMMARY ##.

  • Renal Cancer
  • Market Shares

Kidney Cancer Drugs Market Size, Share & Trends Analysis Report By Therapeutic Class, By Pharmacologic Class, By Country And Segment Forecasts, 2016 - 2022 Chapter ## Research Methodology ##. ##.

  • Cancer
  • Renal Cancer
  • United States
  • Forecast
  • CHAPTER III KIDNEY CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS
  • Market Size

Chart ##: China' s Kidney Cancer Treatment Drugs Sales Volume (Million Yuan) INTRODUCTION Chapter I Kidney Cancer Treatment Drugs Industry Structure CHAPTER III KIDNEY CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS Kidney cancer is usually define

  • Renal Cancer
  • China
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • Roche Group
  • CHAPTER III KIDNEY CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS
  • CHAPTER IV KIDNEY CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

In China, kidney cancer accounts for approximately ##% of all adult cancers.

  • Renal Cancer
  • China
  • Demand
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • Top 20 Countries with Highest Incidence of Kidney Cancer in 2012; Both Sexes
  • Top 20 Countries with Highest Incidence of Kidney Cancer in 2012; Men

Kidney cancer is the twelfth most common cancer diagnosed in the world.

  • Renal Cancer
  • Argos Therapeutics, Inc.
  • AstraZeneca PLC
  • AVEO Oncology
  • Bristol-Myers Squibb Company

Around ##% of all malignant kidney tumors are RCC, with other types including transitional cell carcinoma of the renal pelvis and Wilms tumor (nephroblastoma).

  • Cancer
  • Renal Cancer
  • European Union
  • Japan
  • United States

Kidney Cancer (Renal Cell Cancer) Global Clinical Trials Review, H##, 2020 List of Tables List of Figures Report Guidance GlobalData Clinical Trials Report Coverage Clinical Trials by Region Clinical Trials and Average Enrollment by Country Top Five Countries Contributing t

  • Cancer
  • Clinical Trial
  • Renal Cancer
  • Therapy
  • World
  • CHAPTER IV KIDNEY CANCER TREATMENT DRUGS PRODUCTION AND DEMAND
  • Chapter IV

Shenzhen Kangtai Biological Products Co., Ltd. is one of the biggest cancer vaccines producers in China.

  • Renal Cancer
  • China
  • Demand
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd

Renal Cell Cancer Pricing, Reimbursement, and Access CONTENTS ## OVERVIEW ## REGULATORY LABELS ## Marketed renal cell cancer products in the US, Japan, and five major EU markets ## Bibliography ## GLOBAL ACCESS LEVERS ## Expenditure on RCC medicines poses a moderate concern for

  • Cancer
  • Renal Cancer
  • European Union
  • Japan
  • United States
  • Global Kidney Cancer Drugs Market
  • Global Kidney Cancer Drugs Market

The disease accounts for less than ##% of all kidney cancer cases.

  • Renal Cancer
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Novartis AG
  • Pfizer Inc.
  • Trends in the Five-Year Relative Survival (%) of Kidney Cancers in the 8MM, Both Sexes,
  • presents the temporal trends in the age-adjusted incidence rate of kidney cancers in the

Kidney Cancer.

  • Renal Cancer
  • China
  • Japan
  • United States
  • Forecast
  • presents the temporal trends in the age-adjusted incidence rate of kidney cancers in the
  • TRENDS IN THE FIVE-YEAR RELATIVE SURVIVAL (%) OF KIDNEY CANCERS IN THE 8MM, BOTH SEXES,

KIDNEY CANCER.

  • Renal Cancer
  • Eisai Co., Ltd.
  • Exelixis, Inc.
  • Pfizer Inc.
  • Roche Group
  • The following is the list of drugs in phase 2 or phase 3 development for renal cancer-related indications.
  • Forecast

However, although KIM-## has diagnostic sensitivity for kidney cancer, it is well known to reflect many types of kidney injuries, thus limiting its specificity as a diagnostic marker for renal cancer.

  • Renal Cancer
  • World
  • Exelixis, Inc.
  • Merck & Co., Inc.
  • Rexahn Pharmaceuticals, Inc.
  • B) KIDNEY CANCER
  • 2.5.2 KIDNEY CANCER

There is currently only one recently approved mAb PD-## inhibitor, Opdivo (approved in 2015) which is used to treat metastatic kidney cancer (FDA, 2014a; FDA, 2014b).

  • Renal Cancer
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Johnson & Johnson
  • Pfizer Inc.

Until 1980’s, the treatment of kidney cancer included surgical removal of the kidneys.

  • Renal Cancer
  • Therapy
  • United States
  • World
  • Market Size

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H## 2018 Table of Contents ## Introduction ## Kidney Cancer (Renal Cell Cancer) - Overview ## Kidney Cancer (Renal Cell Cancer) - Therapeutics Development ##

  • Cancer
  • Pathology
  • Renal Cancer

Kidney cancer also called renal cancer is a disease in which kidney cells become malignant (cancerous) and grows out of control, forming a tumor.

  • Cancer
  • Pathology
  • Renal Cancer
  • Therapy
  • Product Initiative

Renal Cancer Treatment: Industry Analysis, R& D Trends and World Market Forecasts 2015-2025 Table of Contents ##.

  • Cancer
  • Renal Cancer
  • Therapy
  • World
  • Market Size
  • 25 May 2012

RCC is the most common type of kidney cancer.

  • Renal Cancer
  • United States
  • GlaxoSmithKline plc
  • Novartis AG
  • Pfizer Inc.

Renal cell cancer

4385 5000 3900
  • RCC IS THE MOST COMMON TYPE OF KIDNEY CANCER
  • EXTRACTING INCIDENCE RATE DATA FOR JAPAN, FRANCE, SPAIN, AND THE UK

Kidney cancer was defined by the IARC as cases with the topographical codes C## (kidney cancer, not of renal pelvis), C## (kidney cancer of renal pelvis), C## (kidney cancer of the ureter), and C## (kidney

  • Renal Cancer
  • European Union
  • Japan
  • North America
  • United States
  • AUG 21, 2013: PAZOPANIB SHOWS BETTER QUALITY-OF-LIFE IN ADVANCED KIDNEY CANCER
  • MAR 31, 2014: VOTRIENT AS MAINTENANCE THERAPY FOR ADVANCED OVARIAN CANCER IN THE EU

Two oral targeted drugs approved for metastatic kidney cancer worked equally well, but one proved superior in tolerability, according to results of a large international clinical trial led by researchers at Dana-Farber Cancer Institute.

  • Immunotherapy
  • Pharmaceutical
  • Renal Cancer
  • Therapy
  • Novartis AG
  • Jul 10, 2017: Kidney Cancer UK delighted NICE recommends cabozantinib on NHS for kidney cancer patients
  • Jun 12, 2017: Scotland first in UK to make Cabometyx (cabozantinib) routinely available for individuals living with advanced kidney cancer

" We believe it brings us one step closer to fighting kidney cancer, which is rapidly on the rise in the UK.

  • Hepatitis
  • Renal Cancer
  • United States
  • Company
  • Exelixis, Inc.
  • Dec 20, 2017: New class of anti-cancer drug effective against kidney cancer

" One of the biggest challenges we face across all treatments for kidney cancer is pairing the right drug with the right patient, " said Dr.

  • Renal Cancer
  • Therapy
  • United States
  • Company
  • Peloton Therapeutics, Inc.
  • AUG 23, 2018: HEIDELBERG PHARMA: PARTNER TELIX PHARMACEUTICALS FILES PHASE III TRIAL FOR KIDNEY CANCER IMAGING IN EUROPE
  • FEATURED NEWS & PRESS RELEASES

All C##(##)/ SV## T-Ag mice in the control and paclitaxel treated groups developed palpable mammary cancer.

  • Brain Cancer
  • Renal Cancer
  • United States
  • World
  • Product Initiative
  • PIPELINE BY HEC PHARM CO LTD, H2 2019
  • FOLLICULAR THYROID CANCER

On average, ##, ## Canadians are diagnosed with kidney cancer each year, and the incidence is growing. iv Unfortunately, many kidney cancers are diagnosed at a later stage, or progress to later stages.

  • Cancer
  • Pharmaceutical
  • Renal Cancer
  • Therapy
  • Exelixis, Inc.

## Antibody In Murine Models Of Colorectal Cancer ## Jun ##, 2018: Surface Oncology Announces Initiation of Phase I Clinical Trial of SRF## / NZV## ## Jun ##, 2018: Arcus Biosciences Announces FDA Clearance of INDs for AB## and AB## and Initiation of Phase ##/ ##

  • Cancer
  • Clinical Trial
  • Drug Development
  • Renal Cancer
  • World
  • IROFULVEN IN TREATING PATIENTS WITH METASTATIC KIDNEY CANCER
  • A TRIAL LOOKING AT RAD001, INTERFERON AND BEVACIZUMAB FOR KIDNEY CANCER THAT HAS SPREAD

FINDINGS FROM AN EXPLORATORY ENDPOINT SHOWED PATIENTS REPORTED STATISTICALLY SIGNIFICANTLY BETTER KIDNEY CANCER SYMPTOM CONTROL WITH THE OPDIVO PLUS YERVOY COMBINATION COMPARED TO SUNITINIB, WHEN ASSESSED USING A VALID TUMOR-SPECIFIC PATIENT-REPORTED KIDNEY

  • Clinical Trial
  • Hospital
  • Monoclonal Antibody
  • Renal Cancer
  • Pfizer Inc.
  • MAR 23, 2018: EXELIXIS PARTNER IPSEN ANNOUNCES POSITIVE CHMP OPINION FOR CABOMETYX (CABOZANTINIB) FOR PREVIOUSLY UNTREATED INTERMEDIATE- OR POOR-RISK ADVANCED RENAL CELL CARCINOMA
  • CABOZANTINIB S-MALATE - DRUG PROFILE

THE FIRST WAS A CLOSELY WATCHED ONE OVER KIDNEY CANCER DRUG SORAFENIB BRANDED NEXAVAR BY BAYER.

  • Hospital
  • Renal Cancer
  • Targeted Therapy
  • Therapy
  • Exelixis, Inc.
  • NOV 21, 2011: MOLOGEN ATTAINS GOALS OF RENAL CANCER STUDY WITH MGN1601 AHEAD OF SCHEDULE
  • FEB 03, 2014: MOLOGEN: FINAL RESULTS FROM RENAL CANCER TRIAL WITH MGN1601 PRESENTED AT ASCO GENITOURINARY CANCERS SYMPOSIUM

In the case of one patient, the size of the metastases was reduced by more than ##%, and in two cases, progress of the renal cancer was stopped.

  • Cancer
  • Renal Cancer
  • World
  • Product Initiative
  • MOLOGEN AG
  • DORMANT PROJECTS, H2 2019
  • PIPELINE BY SIGNALCHEM LIFESCIENCES CORP, H2 2019

The study will enrol ## renal cancer patients.

  • Monoclonal Antibody
  • Pharmaceutical
  • Renal Cancer
  • World
  • Product Initiative